康众医疗
(688607)
| 流通市值：11.36亿 | | | 总市值：11.36亿 |
| 流通股本：8812.90万 | | | 总股本：8812.90万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 52,969,765.8 | 273,743,126.41 | 181,405,325.04 | 110,938,686.53 |
| 营业收入 | 52,969,765.8 | 273,743,126.41 | 181,405,325.04 | 110,938,686.53 |
| 二、营业总成本 | 53,280,817.38 | 263,882,523.32 | 185,434,033.22 | 117,184,477.69 |
| 营业成本 | 30,984,759.69 | 165,210,552.97 | 114,200,570.5 | 70,669,701.59 |
| 税金及附加 | 440,069.25 | 1,165,985.61 | 567,567.66 | 312,241.5 |
| 销售费用 | 7,313,257.47 | 27,349,839.66 | 19,962,539.75 | 13,717,253.19 |
| 管理费用 | 4,914,572.71 | 29,359,890.96 | 20,242,392.75 | 13,599,449.79 |
| 研发费用 | 10,369,812.18 | 44,598,095.92 | 34,762,082.95 | 23,245,546.62 |
| 财务费用 | -741,653.92 | -3,801,841.8 | -4,301,120.39 | -4,359,715 |
| 其中:利息费用 | 202,962.67 | 506,430.84 | 166,107.61 | 136,647.58 |
| 其中:利息收入 | 61,519.5 | 1,493,932.71 | 351,563.2 | 184,742.31 |
| 加:公允价值变动收益 | -216,016.31 | 1,411,334.77 | 1,389,253.57 | 1,389,253.57 |
| 加:投资收益 | 2,482,896.33 | 8,730,140.55 | 5,289,455.94 | 4,033,855.62 |
| 资产处置收益 | - | 185,600.98 | 185,031.34 | - |
| 资产减值损失(新) | -296,541.53 | -5,731,719.1 | -718,862.5 | -335,724.69 |
| 信用减值损失(新) | -292,188.63 | -2,345,613.55 | -849,121.73 | -850,404.51 |
| 其他收益 | 671,246.78 | 1,723,457.49 | 1,147,245.4 | 761,059.03 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 2,038,345.06 | 13,833,804.23 | 2,414,293.84 | -1,247,752.14 |
| 加:营业外收入 | 5,538.09 | 1,474,564.26 | 220,373.45 | 5,395.57 |
| 减:营业外支出 | 4,645.62 | 6,546.15 | 3,751.56 | 3,751.84 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 2,039,237.53 | 15,301,822.34 | 2,630,915.73 | -1,246,108.41 |
| 减:所得税费用 | 848,481.08 | -105,772.08 | -760,799.84 | -183,580.85 |
| 六、净利润 | 1,190,756.45 | 15,407,594.42 | 3,391,715.57 | -1,062,527.56 |
| 持续经营净利润 | 1,190,756.45 | 15,407,594.42 | 3,391,715.57 | -1,062,527.56 |
| 归属于母公司股东的净利润 | 1,168,820.49 | 15,412,206.47 | 3,297,845.75 | -1,110,997.6 |
| 少数股东损益 | 21,935.96 | -4,612.05 | 93,869.82 | 48,470.04 |
| (一)基本每股收益 | 0.01 | 0.17 | 0.04 | -0.01 |
| (二)稀释每股收益 | 0.01 | 0.17 | 0.04 | -0.01 |
| 八、其他综合收益 | -440,983.48 | -1,641,850.68 | 399,017.5 | 1,306,842.98 |
| 归属于母公司股东的其他综合收益 | -440,983.48 | -1,635,559.23 | 399,017.5 | 1,306,842.98 |
| 九、综合收益总额 | 749,772.97 | 13,765,743.74 | 3,790,733.07 | 244,315.42 |
| 归属于母公司股东的综合收益总额 | 727,837.01 | 13,776,647.24 | 3,696,863.25 | 195,845.38 |
| 归属于少数股东的综合收益总额 | 21,935.96 | -10,903.5 | 93,869.82 | 48,470.04 |
| 公告日期 | 2024-04-27 | 2024-04-20 | 2023-10-28 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |